K233764 is an FDA 510(k) clearance for the SSS-NX (Serum Substitute Supplement-NX). This device is classified as a Media, Reproductive (Class II - Special Controls, product code MQL).
Submitted by Fujifilm Irvine Scientific (Santa Ana, US). The FDA issued a Cleared decision on April 24, 2024, 152 days after receiving the submission on November 24, 2023.
This device falls under the Obstetrics & Gynecology FDA review panel. Regulated under 21 CFR 884.6180.
| 510(k) Number | K233764 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | November 24, 2023 |
| Decision Date | April 24, 2024 |
| Days to Decision | 152 days |
| Submission Type | Traditional |
| Review Panel | Obstetrics & Gynecology (OB) |
| Summary | Summary PDF |
| Product Code | MQL - Media, Reproductive |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 884.6180 |